COMT inhibitor

COMT inhibitor is a type of drug that is used to treat various neurological disorders, including Parkinson's disease. COMT stands for Catechol-O-methyltransferase, an enzyme that breaks down certain neurotransmitters in the brain. By inhibiting this enzyme, COMT inhibitors increase the levels of these neurotransmitters, which can help to alleviate symptoms of these disorders.

Mechanism of Action[edit | edit source]

COMT inhibitors work by blocking the action of the enzyme catechol-O-methyltransferase. This enzyme is responsible for the breakdown of dopamine, a neurotransmitter that is often depleted in people with Parkinson's disease. By inhibiting COMT, these drugs increase the availability of dopamine in the brain, which can help to improve motor function and reduce symptoms such as tremors and rigidity.

Uses[edit | edit source]

COMT inhibitors are primarily used in the treatment of Parkinson's disease. They are often used in combination with other drugs, such as levodopa, to enhance their effectiveness. In addition to Parkinson's disease, COMT inhibitors may also be used to treat other neurological disorders that are characterized by low dopamine levels, such as Huntington's disease.

Side Effects[edit | edit source]

Like all drugs, COMT inhibitors can cause side effects. These may include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, they can also cause more serious side effects, such as liver damage or hallucinations. It is important for patients to discuss these potential risks with their healthcare provider before starting treatment with a COMT inhibitor.

Examples[edit | edit source]

There are several different COMT inhibitors that are currently available for use. These include entacapone, tolcapone, and opicapone. Each of these drugs has a slightly different mechanism of action, and may be used in different circumstances depending on the specific needs of the patient.